does fep blue cover tirzepatide Weight glp-1 bcbs fep glp 1

This is not a blunt-force genomic intervention

SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss

All tissue biopsies were placed in a drying chamber until a stable weight was measured for approximately 48 hours

In short: Your HRT might stop working properly You might bleed again after years without a period You might unknowingly increase your risk of womb problems The New BMS Advice: What Should You Be Aware Of